Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1974 Feb 2;1(5900):171–175. doi: 10.1136/bmj.1.5900.171

Steroid Aerosols in Asthma: An Assessment of Betamethasone Valerate and a 12-month Study of Patients on Maintenance Treatment

M K McAllen, S J Kochanowski, K M Shaw
PMCID: PMC1633023  PMID: 4590668

Abstract

Betamethasone valerate aerosol is a new compound for the treatment of asthma. Its clinical effectiveness was established in a double-blind cross-over trial in non-steroid-dependent asthmatic patients. At a dosage of 400 to 800 μg/day for three months there was no evidence of suppression of hypothalamic-pituitary-adrenal function, as assessed by tetracosactrin and insulin stress tests.

A 12-month follow-up study of 120 patients using steroid aerosols (betamethasone valerate or beclomethasone dipropionate) indicated that tolerance does not develop and that a daily maintenance dose of 200 μg/day was adequate in most patients. Temporary lack of response was observed during episodes of sputum production or of heavy exposure to antigen.

There were no observed side effects other than fungal infections of the respiratory tract. However, the incidence of candidiasis of the pharynx (13%) and particularly of the larynx (5%) in apparently immunologically normal patients was disturbing. These infections were not seen in patients taking 200 μg/day. Though there is yet no evidence that fungal infections associated with steroid aerosols may penetrate the trachea and bronchi the possibility of this indicates that caution should be exercised in their use, particularly in long-term high dosage.

Full text

PDF
175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown H. M., Storey G., George W. H. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br Med J. 1972 Mar 4;1(5800):585–590. doi: 10.1136/bmj.1.5800.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Choo-Kang Y. F., Cooper E. J., Tribe A. E., Grant I. W. Beclomethasone dipropionate by inhalation in the treatment of airways obstruction. Br J Dis Chest. 1972 Apr;66(2):101–106. [PubMed] [Google Scholar]
  3. Clark T. J. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet. 1972 Jun 24;1(7765):1361–1364. doi: 10.1016/s0140-6736(72)91094-x. [DOI] [PubMed] [Google Scholar]
  4. Gaddie J., Petrie G. R., Reid I. W., Skinner C., Sinclair D. J., Palmer K. N. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet. 1973 Aug 11;2(7824):280–281. doi: 10.1016/s0140-6736(73)90788-5. [DOI] [PubMed] [Google Scholar]
  5. Lal S., Harris D. M., Bhalla K. K., Singhal S. N., Butler A. G. Comparison of beclomethasone dipropionate aerosol and prednisolone in reversible airways obstruction. Br Med J. 1972 Aug 5;3(5822):314–317. doi: 10.1136/bmj.3.5822.314. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES